UFP Technologies (UFPT) 15th Annual Midwest IDEAS Investor Conference summary

Business overview and value proposition

• Designs and manufactures solutions for medical devices, sterile packaging, and engineered products, generating $565M in revenue with 4,000+ employees across 20 factories in five countries.

• Maintains exclusive or semi-exclusive access to advanced materials through multi-year vendor partnerships, enhancing innovation and product safety.

• Serves over 2,000 customers, including 25 of the top 30 medtech companies, with a process that integrates design, prototyping, tooling, custom equipment, and quality systems.

• Focuses on high-margin, customer-funded product development, leveraging expertise and strong customer relationships for long-term manufacturing contracts.

Key markets and applications

• Robotic surgery is the largest and fastest-growing segment, accounting for 30% of revenue, with multi-year agreements with leading players.

• Other significant markets include interventional surgical devices, patient services, infection prevention, and med-surg beds.

• Acquisitions have enabled forward integration and dominance in key applications, such as robotic drapes and negative pressure wound therapy.

• Advanced components business leverages core materials and processes for aerospace, defense, and automotive markets.

Growth strategy and competitive advantages

• Pursues a two-pronged growth strategy: internal focus on high-value, best-fit markets and external expansion via customer-driven geographic and capability acquisitions.

• Iterative market focus led to specialization in single-use, single-patient medtech applications, with continuous improvement and value-driven customer selection.

• International expansion driven by customer demand, with new facilities in Ireland, Mexico, Dominican Republic, and Costa Rica to capture low-cost manufacturing opportunities.

• Barriers to entry include materials exclusivity, deep customer integration, and a culture of bulletproofing applications.